CRP and coronary artery disorder: [70–72] In a large cohort of CAD patients, Murr et al. [72] showed that elevated Phenylalanine:Tyrosine ratios correlate with high sensitivity CRP levels, a well-established biomarker of adverse cardiovascular outcomes.